Rapid Generation of Therapeutic Nanoparticles Using Cell-Free Expression Systems

Area of Science:

• Biotechnology and Nanomedicine
• Protein Engineering
• Materials Science

Background:

• Surface modification of nanocarriers with targeting proteins is crucial for therapeutics.
• Traditional methods involving cell expression and purification are slow and costly.
• This limits the development of advanced protein-conjugated nanocarriers.

Purpose of the Study:

• To demonstrate a rapid method for creating protein-conjugated membrane-based nanocarriers using cell-free protein synthesis.
• To overcome the limitations of traditional protein conjugation techniques.
• To enable faster design and development of nanomedicines.

Main Methods:

• Utilized cell-free protein synthesis systems for simultaneous protein expression and nanoparticle conjugation.
• Applied the method to liposomes, polymersomes, and lipid nanoparticles.
• Incorporated various binding proteins like affibodies, designed proteins, and scFvs.
• Explored diverse conjugation strategies including surface attachment and membrane integration.

Main Results:

• Successfully achieved one-pot cell-free expression and conjugation of functional proteins to liposomes.
• Demonstrated applicability to polymersomes and lipid nanoparticles with multiple conjugation methods.
• Engineered bispecific artificial antigen-presenting cells rapidly.
• Showcased enhanced in vitro delivery of lipid nanoparticle cargo.

Conclusions:

• Cell-free protein synthesis offers a streamlined workflow for generating protein-conjugated nanocarriers.
• This approach significantly accelerates the creation of cell-mimetic therapeutics.
• The methodology holds promise for advancing nanomedicine development and targeted drug delivery.